Jeremy J Johnson Selected Research

Jeremy J Johnson Research Topics

Disease

18	Neoplasms (Cancer) 07/2022 - 09/2008
12	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 09/2008
3	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2013
3	Wounds and Injuries (Trauma) 01/2021 - 03/2013
3	Carcinogenesis 05/2013 - 09/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2019 - 01/2014
2	Inflammation (Inflammations) 01/2019 - 06/2011
2	Colonic Neoplasms (Colon Cancer) 06/2011 - 02/2009
1	Body Weight (Weight, Body) 11/2021
1	Colitis 02/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Multiple Myeloma 12/2019
1	Hypercholesterolemia 03/2019
1	Neoplasm Metastasis (Metastasis) 12/2015
1	Hematologic Neoplasms (Hematological Malignancy) 10/2015
1	Abscess 05/2013
1	Bacterial Infections (Bacterial Infection) 05/2013
1	Biliary Dyskinesia 04/2013
1	Nonpenetrating Wounds 03/2013
1	Shock 03/2013
1	Melanoma (Melanoma, Malignant) 06/2011
1	Leukemia 06/2011
1	Colorectal Neoplasms (Colorectal Cancer) 02/2009
1	Infections 03/2007

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2009
7	carnosolIBA 11/2021 - 09/2008
5	mangostinIBA 01/2022 - 02/2012
5	salvinIBA 02/2021 - 01/2013
4	PhytochemicalsIBA 01/2022 - 06/2011
4	Pharmaceutical PreparationsIBA 01/2022 - 03/2007
4	DiterpenesIBA 10/2015 - 09/2008
3	XanthonesIBA 01/2022 - 01/2013
3	Androgen Receptors (Androgen Receptor)IBA 01/2016 - 01/2014
3	AndrogensIBA 01/2016 - 09/2010
3	fisetinIBA 06/2011 - 02/2009
2	xanthoneIBA 01/2022 - 02/2012
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2016 - 09/2010
2	TOR Serine-Threonine KinasesIBA 12/2015 - 08/2010
2	Biological ProductsIBA 10/2014 - 01/2013
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2014 - 01/2013
2	PolyphenolsIBA 01/2013 - 01/2013
2	FlavonoidsIBA 06/2011 - 02/2009
2	NF-kappa B (NF-kB)IBA 06/2011 - 02/2009
2	Estrogen ReceptorsIBA 06/2011 - 09/2010
1	kelampayoside AIBA 07/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	EmulsionsIBA 01/2022
1	garcinone CIBA 12/2021
1	1,3,5,8- tetrahydroxy- 2,4- bis(3- methyl- 2- butenyl)xanthoneIBA 12/2021
1	garcinone DIBA 12/2021
1	3-isomangostinIBA 12/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 02/2021
1	Dextrans (Dextran)FDA Link 02/2021
1	SteroidsIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Melphalan (Alkeran)FDA LinkGeneric 12/2019
1	Hemoglobins (Hemoglobin)IBA 12/2019
1	CreatinineIBA 12/2019
1	LDL CholesterolIBA 03/2019
1	CholesterolIBA 03/2019
1	Everolimus FDA Link 12/2015
1	MTOR InhibitorsIBA 12/2015
1	Hormones (Hormone)IBA 12/2015
1	exemestane (Aromasin)FDA Link 12/2015
1	rosmanolIBA 10/2015
1	Small Interfering RNA (siRNA)IBA 10/2014
1	Bromodeoxyuridine (BrdU)IBA 01/2014
1	Polyethylene Terephthalates (Polyethylene Terephthalate)IBA 05/2013
1	Oncogene Proteins (Oncogene Protein)IBA 05/2013
1	Calcium-Binding ProteinsIBA 05/2013
1	Biomarkers (Surrogate Marker)IBA 03/2013
1	AntioxidantsIBA 01/2013
1	CateninsIBA 06/2011
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 06/2011
1	Microphthalmia-Associated Transcription FactorIBA 06/2011
1	Estrogens (Estrogen)FDA Link 09/2010
1	Phosphotransferases (Kinase)IBA 08/2010
1	Dinoprostone (PGE2)FDA Link 02/2009
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2009
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 02/2009
1	AMP-Activated Protein KinasesIBA 09/2008
1	SolutionsIBA 03/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2007
1	Ethanol (Ethyl Alcohol)IBA 03/2007

Therapy/Procedure

5	Chemoprevention 01/2013 - 09/2010
3	Mediterranean Diet 01/2019 - 01/2013
3	Therapeutics 01/2016 - 02/2012
3	Prostatectomy (Retropubic Prostatectomy) 10/2014 - 01/2013
1	Microspheres (Microsphere) 01/2022
1	Parenteral Nutrition 01/2021
1	Stem Cell Transplantation 12/2019
1	Laparoscopic Cholecystectomy 04/2013
1	Laparotomy 03/2013
1	Oral Administration 09/2010